Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Covington
Argus Health
Chubb
Colorcon
Federal Trade Commission
Johnson and Johnson
Accenture
Cipla

Generated: January 21, 2018

DrugPatentWatch Database Preview

CHROMITOPE SODIUM Drug Profile

« Back to Dashboard

Which patents cover Chromitope Sodium, and what generic alternatives are available?

Chromitope Sodium is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in CHROMITOPE SODIUM is sodium chromate cr-51. There are one thousand four hundred and fifteen drug master file entries for this compound. Additional details are available on the sodium chromate cr-51 profile page.
Summary for CHROMITOPE SODIUM
Drug patent expirations by year for CHROMITOPE SODIUM

US Patents and Regulatory Information for CHROMITOPE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco CHROMITOPE SODIUM sodium chromate cr-51 INJECTABLE;INJECTION 013993-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bracco CHROMITOPE SODIUM sodium chromate cr-51 INJECTABLE;INJECTION 013993-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Fish and Richardson
Mallinckrodt
Chubb
Queensland Health
Colorcon
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot